TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36361362

Group type: EXPERIMENTAL
Intervention: Water-based exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Land-based exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 0
Study: 33328395

Group type: COMPARATOR
Intervention: ClearfilTM SE Bond 2 (SE, control)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ClearfilTM Universal Bond (CU)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ScotchBondTM Universal Adhesive (SB)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: RDT
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Smear layer types
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Aging (24h or 1y)
Number of subjects: 96
Study: 32869576

Group type: EXPERIMENTAL
Intervention: Xiao xingnao kaiqiao acupuncture, once daily for 21 days, needles retained for 30 min.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Flunarizine Hydrochloride, 5 mg, once daily for 21 days.
Number of subjects: 90
Study: 34840045

Group type: EXPERIMENTAL
Intervention: Modified Park's submucosal hemorrhoidectomy (MPSH)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy (MMH)
Number of subjects: 186
Study: 32861015

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI), 4 sessions of behavioral therapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-CBTI group, 1 informative session on sleep hygiene
Number of subjects: 25
Study: 34417368

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 379

Group type: COMPARATOR
Intervention: Crystalloids
Number of subjects: 379
Study: 33322678

Group type: EXPERIMENTAL
Intervention: Prompt-60
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Prompt-30
Number of subjects: 56

Group type: COMPARATOR
Intervention: No-Prompt Comparison
Number of subjects: 56
Study: 36395030

Group type: EXPERIMENTAL
Intervention: Body Project
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Media psychoeducation (active control)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 168
Study: 34081399

Group type: EXPERIMENTAL
Intervention: MiMiC (computational approach for data-driven design of simplified communities)
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: MiMiC
Number of subjects: 937
Study: 32420830

Group type: EXPERIMENTAL
Intervention: Dietary habits including drinking pure fruit juice, consuming more meat with less visible fat, and modest salt consumption during cooking
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (without POAG)
Number of subjects: 200
Study: 36458932

Group type: EXPERIMENTAL
Intervention: ONRC (non-regenerated oxidized cellulose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ORC (regenerated oxidized cellulose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ONRC
Number of subjects: 0

Group type: COMPARATOR
Intervention: ORC
Number of subjects: 0
Study: 32668505

Group type: EXPERIMENTAL
Intervention: Steroid-sparing antiemetic protocol using olanzapine (group 2)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Steroid-containing antiemetic protocol (group 1)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study: 34380355

Group type: EXPERIMENTAL
Intervention: Symptom-exaggeration condition (ES group; n=46)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Simulation-only condition (S group; n=38)
Number of subjects: 84
Study: 36459044

Group type: EXPERIMENTAL
Intervention: Benson's relaxation therapy (BRT) plus aerobic exercise (5 sessions per week) for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Benson's relaxation therapy (BRT) only for 8 weeks
Number of subjects: 60
Study: 35675149

Group type: EXPERIMENTAL
Intervention: Cryo-Radial (1-3 cryobiopsies + at least one R-EBUS biopsy via 2.6 mm Guide Sheath)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CT-TTB (CT-guided transthoracic biopsy)
Number of subjects: 48
Study: 36277007

Group type: EXPERIMENTAL
Intervention: Hemp cotton sanitary pads
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Control group (two types of cotton sanitary pads)
Number of subjects: 1002
Study: 33599720

Group type: EXPERIMENTAL
Intervention: Ontamalimab 75 mg every 4 weeks for 72 weeks (OL1)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Ontamalimab 225 mg every 4 weeks for 72 weeks (OL1)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Ontamalimab (combined data from both doses)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo (from TURANDOT study)
Number of subjects: 330
Study: 33147220

Group type: EXPERIMENTAL
Intervention: Amino acids-mineral complexed (AACM) diet with 40, 40 and 2.75 mg/kg of Zn, Mn and Cu, respectively, plus 30, 30 and 5.25 mg/kg of Zn, Mn and Cu from AACM sources
Number of subjects: 800

Group type: COMPARATOR
Intervention: Inorganic minerals (IM) diet with 70, 70 and 8 mg/kg of Zn, Mn and Cu, respectively
Number of subjects: 800
Study: 35385072

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (266 mg) + bupivacaine hydrochloride (100 mg)
Number of subjects: 533

Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride (100 mg) alone
Number of subjects: 533
Study: 33834505

Group type: EXPERIMENTAL
Intervention: Nurse-led, face-to-face, individually-tailored health coaching intervention (4-6 sessions covering six core activation topics)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual primary care (control group)
Number of subjects: 118
Study: 35107614

Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 89

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 89
Study: 32232971

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention based on SMS
Number of subjects: 4501

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4501
Study: 32737085

Group type: EXPERIMENTAL
Intervention: Transgender Education for Affirmative and Competent HIV and Healthcare intervention (TEACHH) workshops
Number of subjects: 150
Study: 35084369

Group type: EXPERIMENTAL
Intervention: Gabapentin (300 mg nightly for 3 days and then 300 mg twice a day for 11 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33517103

Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 36289541

Group type: EXPERIMENTAL
Intervention: IMMENSE intervention (clinical pharmacist intervention)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: IMMENSE intervention
Number of subjects: 480
Study: 32043558

Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation pathway (MRP) consisting of epileptological follow-up, neurocognitive training, emotional support, and social support
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation pathway (MRP)
Number of subjects: 33
Study: 35701314

Group type: EXPERIMENTAL
Intervention: Comprehensive pharmaceutical care intervention added to cardiac rehabilitation program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard cardiac rehabilitation program)
Number of subjects: 40
Study: 32818931

Group type: EXPERIMENTAL
Intervention: Early human albumin solution (HAS)
Number of subjects: 1464
Study: 34032500

Group type: EXPERIMENTAL
Intervention: Symptomatic urethral recurrence (UR)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Asymptomatic urethral recurrence (UR)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Urethral recurrence (UR)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Carcinoma in situ
Number of subjects: 144

Group type: COMPARATOR
Intervention: Multifocal disease
Number of subjects: 144

Group type: COMPARATOR
Intervention: Prostatic urethral involvement at RC
Number of subjects: 144
Study: 32645095

Group type: EXPERIMENTAL
Intervention: Static stretching program (SS) performed once a week
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Static stretching program (SS) performed three times a week
Number of subjects: 24
Study: 35158064

Group type: EXPERIMENTAL
Intervention: 7-day preoperative application of benzoyl peroxide-miconazole nitrate cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: No cream (control group)
Number of subjects: 60
Study: 32747206

Group type: EXPERIMENTAL
Intervention: Intravenous meal administration
Number of subjects: 8
Study: 35968751

Group type: COMPARATOR
Intervention: Dexmedetomidine 0 μg/kg (Control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.6 μg/kg (D1 group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.8 μg/kg (D2 group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 μg/kg (D3 group)
Number of subjects: 100
Study: 33689254

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided postpyloric feeding tube placement
Number of subjects: 115

Group type: COMPARATOR
Intervention: Blind postpyloric feeding tube placement
Number of subjects: 115
Study: 32955051

Group type: EXPERIMENTAL
Intervention: MCN/BIF-20 composite for solid phase extraction
Number of subjects: 0
Study: 35283163

Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 15
Study: 33427129

Group type: EXPERIMENTAL
Intervention: Biofeedback intervention (6 training sessions, once a week)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 36
Study: 36283240

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34959932

Group type: EXPERIMENTAL
Intervention: Astaxanthin (12 mg once daily for 12 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 33005007

Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (per 10 μg/m3 increase)
Number of subjects: 1457

Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (highest versus lowest quartile)
Number of subjects: 1457

Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (high versus low exposure analyses)
Number of subjects: 1457
Study: 33020985

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy-enhanced cognitive behavioural therapy for insomnia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 32
Study: 36084965

Group type: EXPERIMENTAL
Intervention: allo‐hBM‐MSCDs (1 mL, 2 doses)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: allo‐hBM‐MSCs (1 × 10^6 cells, 1 dose)
Number of subjects: 28

Group type: COMPARATOR
Intervention: PolyMem dressing (conventional treatment)
Number of subjects: 28
Study: 33941122

Group type: EXPERIMENTAL
Intervention: Parsplana vitrectomy plus phacoemulsification (phacovitrectomy, PCV, group B)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Parsplana vitrectomy alone (group A)
Number of subjects: 59
Study: 33278328

Group type: EXPERIMENTAL
Intervention: JZP-458 (25 mg/m2 i.m. and 37.5 mg/m2 i.v.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: JZP-458 (i.m. injection)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: JZP-458 (all dose levels)
Number of subjects: 100
Study: 34714289

Group type: EXPERIMENTAL
Intervention: Diclofenac suppository
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Ringer Lactate (RL)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Combination of rectal diclofenac and RL
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control (individual therapy)
Number of subjects: 171
Study: 32047011

Group type: EXPERIMENTAL
Intervention: Systematic approach to screening for depression and assessing patient preferences for depression care.
Number of subjects: 1992

Group type: COMPARATOR
Intervention: Usual care (standard care) provided by general practitioners.
Number of subjects: 1992
Study: 35389229

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major bleeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trivial bleeding
Number of subjects: 0
Study: 34872630

Group type: EXPERIMENTAL
Intervention: Standardized post-coercion review
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (treated as usual)
Number of subjects: 109
Study: 33264387

Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation (CR) interventions
Number of subjects: 126
Study: 32668483

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 39

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 39
Study: 35491539

Group type: EXPERIMENTAL
Intervention: Single ascending dose of Youkenafil Hydrochloride (25, 50, 100, 150, or 200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of Youkenafil Hydrochloride (50, 100, or 150 mg once daily for 7 consecutive days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of Youkenafil Hydrochloride (50 mg) with food
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single and multiple doses of Youkenafil Hydrochloride (up to 200 mg single dose and up to 150 mg multiple doses)
Number of subjects: 0
Study: 34191395

Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5010

Group type: COMPARATOR
Intervention: No AF
Number of subjects: 5010
Study: 32264825

Group type: EXPERIMENTAL
Intervention: Gift exchange at the beginning of the task
Number of subjects: 28

Group type: COMPARATOR
Intervention: Gift exchange halfway through the task
Number of subjects: 28
Study: 33813524

Group type: EXPERIMENTAL
Intervention: Rehabilitation program (12-week brisk walking and diet education)
Number of subjects: 44
Study: 32603956

Group type: EXPERIMENTAL
Intervention: Infliximab (n = 29)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline control (n = 31)
Number of subjects: 60
Study: 34051919

Group type: EXPERIMENTAL
Intervention: Social-Emotional Learning Foundations (SELF) intervention
Number of subjects: 1154

Group type: COMPARATOR
Intervention: Business as Usual (BAU)
Number of subjects: 1154
Study: 33931877

Group type: EXPERIMENTAL
Intervention: Emotion-focused training program (EFTP), 10 sessions
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (interactive activity)
Number of subjects: 120
Study: 35896462

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: COMPARATOR
Intervention: Vitamin C 1000 mg
Number of subjects: 98
Study: 32508270

Group type: EXPERIMENTAL
Intervention: Male teacher/male student dyad
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Female teacher/male student dyad
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Female teacher/female student dyad
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Male teacher/female student dyad
Number of subjects: 648
Study: 35030255

Group type: EXPERIMENTAL
Intervention: Sirolimus plus prednisolone
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sirolimus monotherapy
Number of subjects: 73
Study: 33843404

Group type: EXPERIMENTAL
Intervention: Topical Rifampin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Local saline and cefotaxime (Control)
Number of subjects: 37
Study: 36107883

Group type: EXPERIMENTAL
Intervention: One-Session Treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy
Number of subjects: 0
Study: 32379556

Group type: EXPERIMENTAL
Intervention: Ozone therapy (O3T)
Number of subjects: 6
Study: 32665006

Group type: EXPERIMENTAL
Intervention: ACEMg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 35156936

Group type: EXPERIMENTAL
Intervention: Internet-based audiologist-guided CBT
Number of subjects: 158

Group type: COMPARATOR
Intervention: Weekly monitoring
Number of subjects: 158
Study: 33781334

Group type: EXPERIMENTAL
Intervention: Named entity recognition strategy for Spanish medical texts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three best neural network architectures tested with MEDDOCAN challenge dataset
Number of subjects: 0
Study: 32077730

Group type: EXPERIMENTAL
Intervention: Emotion coaching (EC) parenting intervention
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Children of mothers in the EC intervention group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 50
Study: 35974379

Group type: EXPERIMENTAL
Intervention: Ankle isokinetic rehabilitation programme for 6 weeks (at least 25 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation for 6 weeks
Number of subjects: 60
Study: 33975925

Group type: EXPERIMENTAL
Intervention: CALLS intervention (12-weekly phone sessions with patient navigator)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 30
Study: 32666402

Group type: COMPARATOR
Intervention: Brexanolone injection (not specified dosage or duration)
Number of subjects: 0
Study: 36174629

Group type: EXPERIMENTAL
Intervention: Niraparib plus nivolumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Niraparib plus ipilimumab (3 mg/kg intravenously every 3 weeks for four doses)
Number of subjects: 0
Study: 33011429

Group type: EXPERIMENTAL
Intervention: Virtual reality training with a VR image of walking through narrow apertures.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group walking through a wide aperture without body rotation.
Number of subjects: 25
Study: 34991364

Group type: COMPARATOR
Intervention: Proposed interventional treatment in a double-blinded, randomized, placebo-controlled clinical trial
Number of subjects: 875
Study: 32633040

Group type: EXPERIMENTAL
Intervention: 2-mm inter-implant distance
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3-mm inter-implant distance
Number of subjects: 30
Study: 34210725

Group type: COMPARATOR
Intervention: CM Attendance
Number of subjects: 552

Group type: COMPARATOR
Intervention: CM Abstinence
Number of subjects: 552
Study: 34910380

Group type: EXPERIMENTAL
Intervention: BSC plus a 10% urea‐based cream
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: BSC plus a moisturising cream
Number of subjects: 129

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 129
Study: 33291020

Group type: EXPERIMENTAL
Intervention: Swaddled
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-swaddled
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Swaddled and Non-swaddled
Number of subjects: 40
Study: 32061969

Group type: EXPERIMENTAL
Intervention: AFL intervention (12 weeks of semiweekly sports skill programming and nutrition sessions for children; sports-focused activity and behavior change sessions for parents)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: AFL intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 160
Study: 35636031

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 86
Study: 32220766

Group type: EXPERIMENTAL
Intervention: Second-party norm violations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Third-party norm violations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both second- and third-party violations
Number of subjects: 0
Study: 36357559

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (NMB)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Moderate neuromuscular block (NMB)
Number of subjects: 128
Study: 33149205

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg/day for three consecutive days
Number of subjects: 1669

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1669
Study: 36002314

Group type: EXPERIMENTAL
Intervention: Adverse drug reactions (ADRs)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: New drugs involved in ADRs
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preventability of ADRs
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Situations of noncompliance
Number of subjects: 100
Study: 32334060

Group type: EXPERIMENTAL
Intervention: Adequate primary end point reporting
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Missed definition of primary end points
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Undefined timing of primary end points
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Discrepancies between registration and publication
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Inability to valuate prespecification of primary end points
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Multicenter studies and sponsor‐initiated trials
Number of subjects: 134
Study: 32486104

Group type: EXPERIMENTAL
Intervention: Etoricoxib combined with individualized exercise programs
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Combination therapy (Etoricoxib + exercise)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Etoricoxib
Number of subjects: 92
Study: 36361100

Group type: EXPERIMENTAL
Intervention: Resistance training with six sets of 20 repetitions maximum (RM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 19
Study: 32544283

Group type: EXPERIMENTAL
Intervention: Robot-assisted ventral mesh rectopexy (RVMR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laparoscopic ventral mesh rectopexy (LVMR)
Number of subjects: 30
Study: 35609642

Group type: EXPERIMENTAL
Intervention: Sacrospinous ligament fixation
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Uterosacral ligament suspension
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Return to work within 6 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Return to work within 2 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patients working before surgery
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patients returning to work
Number of subjects: 180
Study: 33051719

Group type: EXPERIMENTAL
Intervention: Tranexamic acid infiltrated tumescent solution (0.1%)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control tumescent solution (saline, bupivacaine lignocaine and adrenalin without tranexamic acid)
Number of subjects: 33
Study: 35303025

Group type: EXPERIMENTAL
Intervention: Shame
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Guilt
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Guilt and Alcohol Use
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Other Drug Use
Number of subjects: 110